| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.09(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $525.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
25,196 |
31,807 |
32,117 |
57,267 |
| Total Sell Value |
$12,607,111 |
$15,795,731 |
$15,943,511 |
$27,492,928 |
| Total People Sold |
4 |
5 |
6 |
7 |
| Total Sell Transactions |
4 |
7 |
8 |
13 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-06-09 |
4 |
S |
$487.45 |
$3,091,872 |
D/D |
(6,328) |
14,529 |
|
-0% |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-06-09 |
4 |
OE |
$232.04 |
$1,806,785 |
D/D |
6,328 |
20,857 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2022-06-06 |
4 |
S |
$497.14 |
$208,799 |
D/D |
(420) |
9,491 |
|
5% |
|
| Peru Ramiro G |
Director |
– • – |
2022-05-19 |
4 |
AS |
$468.88 |
$464,191 |
D/D |
(990) |
9,405 |
|
-5% |
|
| Jallal Bahija |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
3,342 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
9,911 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
10,395 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
5,154 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
856 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
8,194 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
10,061 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
3,479 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
9,446 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-10 |
4 |
AS |
$458.68 |
$8,155,863 |
D/D |
(17,703) |
12,161 |
|
-3% |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-10 |
4 |
OE |
$131.80 |
$243,566 |
D/D |
1,848 |
29,864 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-03 |
4 |
S |
$463.68 |
$1,123,497 |
D/D |
(2,423) |
1,902 |
|
-0% |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-03 |
4 |
OE |
$271.27 |
$457,562 |
D/D |
1,559 |
4,325 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$206,717 |
D/D |
(446) |
28,438 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,420 |
56,181 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$191,421 |
D/D |
(413) |
57,601 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$24,101 |
D/D |
(52) |
2,766 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2022-03-02 |
4 |
D |
$463.49 |
$762,441 |
D/D |
(1,645) |
120,639 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$228,501 |
D/D |
(493) |
28,016 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$50,984 |
D/D |
(110) |
14,529 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$225,720 |
D/D |
(487) |
60,731 |
|
- |
|
113 Records found
|
|
Page 1 of 5 |
|
|
18.22 (3.59%) 
